Posts by: Iqra Mumal

News

Bowel rest — in which patients do not ingest any food and are fed intravenously — does not significantly lower perforation rates or improve overall outcomes in non-Hodgkin’s lymphoma patients ... Read more

April 20, 2018

Patients with Peripheral T-cell Lymphoma Resistant to First-Line Therapy Show Worse Outcomes, Study Finds

News

Patients with peripheral T-cell lymphomas receiving standard treatment have worse outcomes if they are not responsive to first-line therapy, a prospective study shows. Bone marrow transplants undertaken after these therapies ... Read more

March 29, 2018March 29, 2018

CAR T-cell Therapies Deemed Cost-effective for B-cell Cancers in New Report

News

Treatment with chimeric antigen receptor (CAR) T-cell therapies in B-cell cancers, like certain types of lymphoma and leukemia, is associated with an increase in quality-adjusted and overall survival compared ... Read more

March 15, 2018

Stem Cell Transplants Bring Long-term Benefits to Relapsed Follicular Lymphoma Patients

News

Results from a recent large-scale study indicate that stem cell transplants should be considered for the treatment of patients with relapsed follicular lymphoma. The study, “Allogeneic Hematopoietic Stem Cell ... Read more

March 5, 2018March 5, 2018

Stem Cell Transplants Can Benefit Lymphoma Patients Who Fail to Respond to Chemo, Study Shows

News

Stem cell transplants can lead to excellent outcomes in certain B-cell lymphoma patients who failed to respond to chemoimmunotherapy, a study shows. The results apply to patients with primary mediastinal B-cell ... Read more

February 27, 2018

Phase 2 Study of KD025 Shows Encouraging Clinical Response in Patients with Graft-versus-host Disease

News

Treatment with KD025 is safe and effectively reduces the manifestations of graft-versus-host disease in patients receiving steroids for the condition, or whose condition worsened while on steroids, Kadmon Holdings announced. Those ... Read more

February 12, 2018February 12, 2018

Gene Sequencing Technique Accurately Detects Cancer-specific Mutations in Lymphoid Tumors

News

Capture hybridization-based sequencing, a gene sequencing technique, is superior for the detection of lymphoid cancer-associated mutations in a panel of 32 genes, a new study shows. This approach, compared ... Read more

December 20, 2017December 20, 2017

Key Genes in T-cell Lymphoma Patients Often Missing Agent That Blocks Cancer Signaling, Study Says

News

The tumor suppressor PD-1, which serves as shut-off switch to prevent damaged T-cells from continuing to develop and proliferate, is frequently missing in crucial genes of patients with T-cell lymphomas, ... Read more

September 1, 2017

Lymphoma Patient’s Brain Tumor Disappeared After She Received JCAR017, Study Reports

News

Juno Therapeutics‘ immunotherapy JCAR017 eliminated a brain tumor in a patient whose lymphoma had spread to her brain, researchers at Massachusetts General Hospital Cancer Center reported. The team wrote about ... Read more

August 19, 2017August 19, 2017

FDA Approves Besponsa for Acute Lymphoblastic Leukemia

News

Pfizer Inc. announced that the FDA has approved Besponsa (inotuzumab ozogamicin) for treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). “For adult patients with B-cell ALL ... Read more

Posts by: Iqra Mumal

Iqra Mumal

Bowel Rest Not Seen to Benefit NHL Patients with Gastrointestinal Involvement in Study

Patients with Peripheral T-cell Lymphoma Resistant to First-Line Therapy Show Worse Outcomes, Study Finds

CAR T-cell Therapies Deemed Cost-effective for B-cell Cancers in New Report

Stem Cell Transplants Bring Long-term Benefits to Relapsed Follicular Lymphoma Patients

Stem Cell Transplants Can Benefit Lymphoma Patients Who Fail to Respond to Chemo, Study Shows

Phase 2 Study of KD025 Shows Encouraging Clinical Response in Patients with Graft-versus-host Disease

Gene Sequencing Technique Accurately Detects Cancer-specific Mutations in Lymphoid Tumors

Key Genes in T-cell Lymphoma Patients Often Missing Agent That Blocks Cancer Signaling, Study Says

Lymphoma Patient’s Brain Tumor Disappeared After She Received JCAR017, Study Reports

FDA Approves Besponsa for Acute Lymphoblastic Leukemia

Pin It on Pinterest